China Pharma Holdings - Stock Split History | CPHI

Stock split history for China Pharma Holdings since 2019. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
China Pharma Holdings Annual Stock Splits
China Pharma Holdings Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.010B $0.012B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $61.086B 11.14
Teva Pharmaceutical Industries (TEVA) Israel $10.724B 4.36
Bausch Health Cos (BHC) Canada $10.203B 6.73
Mylan (MYL) United States $9.755B 4.38
Dr Reddy's Laboratories (RDY) India $6.645B 17.43
ASPEN PHARMACR (APNHY) South Africa $3.470B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.152B 11.15
Amphastar Pharmaceuticals (AMPH) United States $0.893B 46.42
Homology Medicines (FIXX) United States $0.783B 0.00
Voyager Therapeutics (VYGR) United States $0.509B 0.00
Akorn (AKRX) United States $0.462B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.431B 0.00
Assembly Biosciences (ASMB) United States $0.417B 0.00
Mallinckrodt Public (MNK) United Kingdom $0.284B 0.39
Adamas Pharmaceuticals (ADMS) United States $0.182B 0.00
Sol-Gel Technologies (SLGL) Israel $0.170B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.131B 0.00
CymaBay Therapeutics (CBAY) United States $0.114B 0.00
Teligent (TLGT) United States $0.034B 0.00